Advanced search
Publication Cover
Infection and Drug Resistance Volume 17, 2024 - Issue
Submit an article Journal homepage
13
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Analysis of Drug Resistance Characteristics of Mycobacterium Tuberculosis in Anhui Province, 2016-2022

Xundi Bao1 Clinical Laboratory, Anhui Provincial Chest Hospital (Provincial Institute of Tuberculosis Control), Hefei, Anhui, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6596-2081View further author information
ORCID Icon,
Shuo Liang1 Clinical Laboratory, Anhui Provincial Chest Hospital (Provincial Institute of Tuberculosis Control), Hefei, Anhui, People’s Republic of ChinaView further author information
,
Jun Li1 Clinical Laboratory, Anhui Provincial Chest Hospital (Provincial Institute of Tuberculosis Control), Hefei, Anhui, People’s Republic of ChinaView further author information
,
Qian Ye1 Clinical Laboratory, Anhui Provincial Chest Hospital (Provincial Institute of Tuberculosis Control), Hefei, Anhui, People’s Republic of ChinaView further author information
,
Dandan Wu1 Clinical Laboratory, Anhui Provincial Chest Hospital (Provincial Institute of Tuberculosis Control), Hefei, Anhui, People’s Republic of ChinaView further author information
,
Shu Wang2 Department of Science and Education, Anhui Provincial Chest Hospital (Provincial Institute of Tuberculosis Control), Hefei, Anhui, People’s Republic of ChinaView further author information
,
Yue Li1 Clinical Laboratory, Anhui Provincial Chest Hospital (Provincial Institute of Tuberculosis Control), Hefei, Anhui, People’s Republic of ChinaView further author information
,
Yunsheng Ding1 Clinical Laboratory, Anhui Provincial Chest Hospital (Provincial Institute of Tuberculosis Control), Hefei, Anhui, People’s Republic of ChinaView further author information
&
Jie Liu3 Tuberculosis Control Institute, Anhui Provincial Chest Hospital (Provincial Institute of Tuberculosis Control), Hefei, Anhui, People’s Republic of ChinaView further author information
 show all
Pages 2485-2499 | Received 23 Feb 2024, Accepted 14 Jun 2024, Published online: 19 Jun 2024

References

  • World Health Organization. Global Tuberculosis Report 2023. Geneva: WHO; 2023.
  • Bao X, Liang S, Li J, et al. Analysis of Mycobacterium tuberculosis drug resistance monitoring in Anhui Province from 2016 to 2022[J]. Chin J Antitubercul. 2024;46(5):531–537. doi:10.19982/j.issn.1000-6621.20240029
  • Zhao Y, Pang Y. Tuberculosis Laboratory Testing Procedures. Beijing: People’s Medical Publishing House; 2015.
  • Wang S, Zhou Y, Ou X, et al. Current status of tuberculosis drug resistance in China: analysis of data from the national tuberculosis drug resistance surveillance in 2018 [J]. Chin J Antituberculosis. 2021;43(11):1141–1147. doi:10.19982/j.iscn.1000-6621.20220268
  • Ministry of Health of the People’s Republic of China. National Baseline Survey on Tuberculosis Drug Resistance: 2007–2008. Beijing: People’s Medical Press; 2010.
  • World Health Organization. Guidelines for Surveillance of Drug Resistance in Tuberculosis. 6th ed. Geneva: World Health Organization; 2021.
  • Bai H, Guo JW, Hu PL, et al. Analysis of drug resistance surveillance results of Mycobacterium tuberculosis in drug resistance monitoring sites of Hunan province from 2014 to 2018 [J]. Chin J Antituberculosis. 2021;43(4):364–369.
  • Zhou Y, Liu R, Du YG, et al. Drug susceptibility analysis of 128 multi-drug resistant Mycobacterium tuberculosis strains in Hainan province, 2014–2016. Chin J Trop Med. 2018;18(6):551–554.
  • Zhao J, Jiang Y, Wu W, et al. Detection and analysis of drug resistance genes of Mycobacterium tuberculosis in three surveillance sites in Jiangxi province [J]. Dis Surveillance. 2022;37(1):127–131.
  • Luo M, Zou X, Gao Y, et al. Effect of anti-tuberculosis treatment and lung injury in patients with tuberculosis complicated with underlying diseases [J]. J Shanghai Jiaotong Univ. 2023;43(8):1017–1023.
  • Wang Q, Ma D, Liu J, et al. Analysis of baseline sampling survey results of drug resistance in smear-positive pulmonary tuberculosis patients in Anhui province [J]. Chin J Antitubercul. 2018;40(8):825–833. doi:10.3969/j.issn.1000-6621.2018.08.010
  • Zhang J, Li H, Wang F, et al. Drug resistance analysis in retreated tuberculosis patients at tuberculosis control agencies in Beijing. J Clin Pulm Med. 2023;28(8):1185–1189.
  • Ge Q, Zhang L, Huang X, et al. Efficacy verification of a novel treatment scheme for initial retreatment of sensitive pulmonary tuberculosis. Chin J Antitubercul. 2023;45(11):1078–1083. doi:10.19982/j.issn.1000-6621.20230192
  • Yu X, Wang L. Analysis of Drug Sensitivity in 402 Clinical Isolates of Mycobacterium Tuberculosis. J Chin Health Inspect. 2023;33(19):2340–2342, 2346.
  • Yang C, Luo T, Shen X, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis in Shanghai, China: a retrospective observational study using whole-genome sequencing and epidemiological investigation. Lancet Infect Dis. 2017;17(3):275–284. doi:10.1016/S1473-3099(16)30418-2
  • Gao Q, Mei J. Transmission is the main reason for the high drug resistance rate of tuberculosis in China. Chin J Antituberculosis. 2015;37(11):1091–1096. doi:10.3969/j.issn.1000-6621.2015.11.002
  • Wang S, Zhao B, Song Y, et al. Risk Factors for Drug-Resistant Tuberculosis in China: an Analysis of Data from the 2007 National Baseline Survey on Tuberculosis Resistance. Chin J Antituberculosis. 2013;35(4):221–226.
  • Gao WF, Yang Y, Wang WN, et al. Analysis of Tuberculosis Drug Resistance at Ten Drug Resistance Monitoring Sites in Sichuan Province, 2016–2017. J Prev Med Inf. 2019;35(7):681–686.
  • Zhong MH, Yan L, Li WH, et al. Analysis of Drug Resistance Characteristics of Mycobacterium Tuberculosis in Dongguan City, 2018. J Guangdong Pharm Univ. 2020;36(2):259–265. doi:10.16809/j.cnki.2096-3653.2019121403
  • Hang NT, Maeda S, Lien LT, et al. Primary Drug-Resistant Tuberculosis in Hanoi, Vietnam: present Status and Risk Factors. PLoS One. 2013;8(8):e71867. doi:10.1371/journal.pone.0071867
  • Li J, Zhang YY, Wu J, et al. Trend of Drug Resistance of Tuberculosis in Shanghai from 2007 to 2012. Chin J Antituberculosis. 2014;36(1):25–30. doi:10.3969/j.issn.1000-6621.2014.01.006
  • Lin M, Liao J, Gong Y, et al. Diabetes and Multidrug-Resistant Gene Mutations Associated with Tuberculosis in Zunyi, Southwest China. Ann Palliat Med. 2020;9(5):3152–3161. doi:10.21037/apm-20-1368
  • Williams V, Vos-Seda AG, Haumba S, et al. Diabetes-Tuberculosis Care in Eswatini: qualitative Study of Opportunities and Recommendations for Effective Services Integration. Int J Public Health. 2023;68:1605551. doi:10.3389/ijph.2023.1605551
  • Ozma MA, Rashedi J, Poor BM, et al. Tuberculosis and Diabetes Mellitus in the Northwest of Iran. Infect Disord Drug Targets. 2020;20(5):667–671. doi:10.2174/1871526519666190715142100

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.